Abraham Morgentaler, MD, FACS, presented “Androgen Society 3rd Annual Meeting Review (Day 2)” for the Grand Rounds in Urology audience in May 2021.

How to cite: Morgentaler, Abraham. “Androgen Society 3rd Annual Meeting Review (Day 2)” May 2021. Accessed Jul 2024. https://grandroundsinurology.com/androgen-society-3rd-annual-meeting-review-day-2/


Abraham Morgentaler, MD, FACS, Associate Clinical Professor of Urologic Surgery at Harvard University, reviews the second day of the 3rd annual meeting of the Androgen Society, an international organization consisting of healthcare professionals interested in testosterone deficiency and its treatment. The day began with presentations on testosterone therapy and type 2 diabetes by Gary Wittert, MD, Hugh Jones, MD, and Farid Saad, MD. These presenters suggested that testosterone could lead to remission of diabetes mellitus, potentially prevent diabetes, and improve glycemic control. They were followed by a presentation on testosterone, anemia, and hematocrit by Sudarshan Ramachandran, PhD, one on COVID-19 and testosterone by Mary Samplaski, MD, and a panel discussion on testosterone’s impact on prostate cancer. Mohit Khera, MD, presented on the possibility of testosterone therapy performing a protective and/or therapeutic role against prostate cancer. Sharon Parish, MD, and Leah Millheiser, MD, presented on testosterone therapy for women and how it benefits sexual function. The day concluded with a presentation by Daniel Kelly, MD, on the complex, context-dependent relationship between testosterone and atherosclerosis.

A summary of day one of the meeting can be watched here. A summary of the third day of this conference will be posted next week on GRU. For more on ADT, visit our Next Generation Androgen Deprivation Therapy Learning Center.


Abraham Morgentaler, MD, graduated from Harvard College in 1978 and Harvard Medical School in 1982. Dr. Morgentaler completed his residency in 1988 through the Harvard Program in Urology, and then joined the faculty of Beth Israel Deaconess Medical Center and Harvard Medical School. He is currently an Associate Clinical Professor of Surgery (Urology) at Harvard Medical School. In 1999, Dr. Morgentaler founded Men's Health Boston, the first center in the US to focus on sexual, reproductive, and hormonal health for men. Dr. Morgentaler was the recipient of the New Investigator Award in 1994 granted by the American Foundation of Urological Disease. Dr. Morgentaler is an international authority on men’s health and a pioneer in the treatment of testosterone deficiency in men. Dr. Morgentaler’s research is credited with reversing the decades-old belief that testosterone therapy is risky for prostate cancer. Dr. Morgentaler has published over 120 scientific articles on testosterone, prostate cancer, male sexual dysfunction, and male infertility. His work has appeared in The New England Journal of Medicine, The Lancet, The Journal of the American Medical Association, Cancer, and The American Journal of Medicine. He is the author of the book Why Men Fake It: The Totally Unexpected Truth About Men and Sex, which has been widely hailed as a groundbreaking exploration of male sexuality. Dr. Morgentaler’s other books include Testosterone For Life: Recharge Your Vitality, Sex Drive, Muscle Mass, and Overall Health, and The Viagra Myth: The Surprising Impact on Love and Relationships.